MentionFox
Home › funding signals › PharmassetX Inc.
Form D · on the record

PharmassetX Inc. — $50K Form D filing, October 2025

PharmassetX Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-10.

PharmassetX Inc. filed a Form D notice of an exempt securities offering with the SEC on October 10, 2025. The filing reports $50K sold. Its industry group is Pharmaceuticals. It names Terry Minton (Chief Executive Officer), David McClure (Chief Operating Officer), Gerald Dryden (Chief Medical Officer) (SEC Form D, October 10, 2025).

5 more Pharmaceuticals raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on PharmassetX Inc. →

Sell to companies like PharmassetX Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

PharmassetX Inc.

New Form D on file · 2025-10-10 · the record

$50K
raise on the record
D
filing
1
investors in
KENTUCKY
based
Open the record →

What the record says

FilingForm D
Filed2025-10-10
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedLouisville, KENTUCKY
CIK2090938
Accession0002090938-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns PharmassetX Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind PharmassetX Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with PharmassetX Inc.?

Get the full cited report on PharmassetX Inc.

What the filing shows about PharmassetX Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on PharmassetX Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives PharmassetX Inc.'s address as 2900 Lake Vista Drive, Louisville, KY 40241.

What the filing says

  • Offered: $20,000,000. Sold: $50,000. Left to sell: $19,950,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: September 10, 2025. (filing)
  • Types of securities: Other: Simple Agreement for Future Equity (SAFE). (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on PharmassetX Inc. See pricing

Is PharmassetX Inc. a real, registered company?

PharmassetX Inc. is a registered filer with the SEC (CIK 2090938) and has filed since 2025-10-10. 2 filings are on record, the latest on 2026-05-04.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs PharmassetX Inc.?

PharmassetX Inc.'s Form D of 2025-10-10 names Terry Minton, David McClure and Gerald Dryden as its officers, directors or promoters.

How much has PharmassetX Inc. raised?

Its new offerings report $150K sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2025-10-10 · $50K · this pageForm D · 2026-05-04 · $100K 2025-10-10 2026-05-04

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week

Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.

Want the whole picture on PharmassetX Inc.?

What the filing shows about PharmassetX Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on PharmassetX Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on PharmassetX Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind PharmassetX Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for PharmassetX Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

PharmassetX Inc.: Raised $50K, Form D filed 2025-10-10
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/pharmassetx-inc-form-d-25000001
Last updated 2026-10-30
Primary record: SEC filing 1 · SEC filing 2
PharmassetX Inc. raised $50K — SEC Form D filing, October 2025. MentionFox, 2026-10-30. https://mentionfox.com/funding/pharmassetx-inc-form-d-25000001